Private ops for common conditions are rocketing due to NHS restrictions, new figures reveal
Graeme Wakerley, a retired haematologist, was diagnosed with an inguinal hernia and had no choice but to pay for surgery
NOT WAITING AROUND Private ops for common conditions are rocketing due to NHS restrictions, new figures reveal
Click to share on X/Twitter (Opens in new window)
Click to share on Facebook (Opens in new window)
PRIVATE medical procedures for common conditions are rocketing as the NHS restricts access or stops funding them altogether, new figures reveal.
Operations such as cataract surgery went up by 39 per cent, hernia repair by 110 per cent and tonsillectomies by 105 per cent - with procedures like these deemed 'of limited value' by the NHS.
1
Private hernia repairs have gone up 110 per cent
Credit: Getty
Analysis of the latest data from the Private Healthcare Information Network (PHIN) also revealed private admissions in England for breast reductions have increased by 61 per cent, and circumcision by 118 per cent.
While carpal tunnel syndrome treatment (64 per cent), and adenoid removals (145 per cent) are all on the increase, according to statistics.
The numbers have risen since the introduction of a list of procedures aimed at guiding NHS commissioners away from funding these treatments.
The Evidence-based Intervention (EBI) list was created to reduce the number of medical or surgical interventions which could be inappropriate for some patients in some circumstances- and to save the NHS money.
Jim Easton of Practice Plus Group hospitals, which performed the analysis, said: "It is correct that there are proper eligibility criteria to ensure that only those people who will benefit from surgery are offered it.
"In the last six years, however, through a combination of the COVID backlog, increasing financial pressures on the NHS, and the growing list of procedures they actively try to restrict, we have seen a marked increase in people in debilitating pain or discomfort who are perfect candidates for surgery but can't get the referral.
"The NHS needs to take care to ensure the EBI programme is not drifting from one intended to benefit patients and reduce unnecessary interventions to one that is more intent on cost-cutting.
"More and more patients are voting with their feet and continuing to seek out these surgeries even if they have to pay for them.
"The EBI list has also created a postcode lottery, for example, where in one area it has adopted the list in its entirety and someone would find it almost impossible to get the treatment they need, in another, the NHS commissioners have recognised their population needs and adapted the list.
"The knock-on effect in not offering these treatments is the gradual disappearance of specialists with enough experience in delivering them, or enough younger doctors trained to perform them."
NHS wait lists rise again
Graeme Wakerley, 71, a retired haematologist who worked for many years in the NHS, was diagnosed with an inguinal hernia in 2023 but was unable to access surgery via them, so he chose to pay for Wellsoon private healthcare from Practice Plus Group.
He said: "A scan showed that the hernia wasn't strangulated which meant it wasn't considered dangerous and I would not be able to get surgery to fix it.
"The GP explained that unless it's strangulated, you're in severe pain or mental anguish, there was no point in applying for funding as I wouldn't get surgery.
"Even when you do get on the list meaning it's serious and you're in severe pain, there would be a two-year wait for hernia surgery."
"So, I had no choice but to pay. I have heard of many other people in similar situations. GPs are having to advise people to go private for surgery because there are so many restrictions on funding."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Glasgow Times
38 minutes ago
- Glasgow Times
Weight-loss jabs may need to be taken for life, experts warn
The drugs are sold under brand names like Mounjaro and Wegovy and work by reducing food cravings. Obese patients can currently be prescribed the jabs on the NHS after being referred to specialist weight loss clinics, which are usually located in hospitals. Hundreds of thousands of people also access the medication privately at pharmacies. There have been warnings about buying potentially unsafe jabs online from unregulated retailers and potentially missing out on wraparound support. Experts said the jabs should not be seen as the first option in weight loss and should be used in conjunction with lifestyle changes, such as eating more healthily and increasing exercise. Professor Graham Easton, a GP who has been using weight loss jabs himself, said: 'I think it's a major issue about the proper funding and resourcing of not only the GPs in the surgeries but also the wraparound care we talked about. 'I think the other issue is that so far, to my knowledge, the NHS and National Institute for Health and Care Excellence have talked about this being something you take for two years, and that's probably related to data from research studies. 'But as we discussed, this is likely to be a lifelong commitment if it is going to be worthwhile to the NHS. 'There's no point in most people taking it for a couple of years and then have the weight bouncing back. 'You can argue possibly you're about to prepare for surgery or something, but in most cases it doesn't make any sense. 'Then I think there's a big issue around access. Most obesity occurs in poorer populations as wealthier populations tend to not be so affected. 'There's a massive sort of socio-economic inequality and there is a worry about this driving that inequality even further. 'Unless the NHS makes sure that these are available across the board equally, I think that's a major risk.' Prof Easton said recent studies had shown people who stopped taking the drugs had put the weight they lost back on within around a year. 'That's often true of any diet, people would say, and that's certainly my experience of having wrestled with my weight in diets over the years,' he said. 'All I would say that I found interesting from that review was that they were suggesting perhaps that weight returns even quicker after having been on GLP-1 drugs. 'Then speculating, because there was no way of knowing from that review, that perhaps it's because people are not changing the behaviours we've been talking about like exercise and other lifestyle changes, just relying on the drugs. 'When you stop them, of course, you're going to put weight back on. The switch is turned back off, or whatever it was. 'I mean very similar to, for example, statins or anti-hypertensive blood pressure medications, if you want lifelong effects, you have to keep on them lifelong.' Prof Easton was speaking at an event at the Cheltenham Science Festival discussing the growing use of weight loss drugs with neurophysiologist Dr Simon Cork and consultant endocrinologist and obesity expert Dr Tony Goldstone. Hundreds of thousands of people access weight-loss medication privately (PA) Dr Cork said the jabs have an important role to play in losing weight but are part of wider changes to diet and lifestyle. 'I think we have to understand that diet is always limited. People will tend to lose on average around 5% of their body weight on a diet,' he said. 'But you're hungry, you're miserable, you're tired, your wife hates you because you're so grumpy, you're not going to continue with that. 'But we should absolutely all be looking at our diet and all changing our diet, and doing something.' Dr Goldstone said weight loss drugs had been used in the treatment of diabetes for over a decade and had benefits of reducing the risk of developing other conditions. 'We're now in the third and fourth generation of these drugs, but the first generation of these drugs we've been using for 15 years for diabetes,' he said. 'There is nothing of concern that has emerged. In fact, all we're seeing are benefits. I'm not too worried about longer term side effects coming out. 'There is no real biological reason why there should be dangerous side-effects in the way that we know these drugs work. 'The benefits of the weight loss improvement in the diabetes are actually by themselves helping health and preventing other diseases, like cancer, heart attacks, renal failure, and potentially even reducing the risk of Alzheimer's disease. 'All those benefits, even if there was something that we hadn't really thought of that emerged down the line, I suspect that the harm of that is outweighed by the potential benefits of weight loss improvement in diabetes control.' Dr Cork said no drug is without side-effects and previous weight loss medications had failed because of them. 'There are side-effects, there are some concerning side-effects that tend to be very rare, but then you can monitor for those side-effects,' he said. 'As long as you're getting the correct care, as long as your GP is aware that you're taking them, then those should be identified. 'If you do find those side-effects, you can stop taking the drug.'
South Wales Argus
an hour ago
- South Wales Argus
Weight-loss jabs may need to be taken for life, experts warn
The drugs are sold under brand names like Mounjaro and Wegovy and work by reducing food cravings. Obese patients can currently be prescribed the jabs on the NHS after being referred to specialist weight loss clinics, which are usually located in hospitals. Hundreds of thousands of people also access the medication privately at pharmacies. There have been warnings about buying potentially unsafe jabs online from unregulated retailers and potentially missing out on wraparound support. Experts said the jabs should not be seen as the first option in weight loss and should be used in conjunction with lifestyle changes, such as eating more healthily and increasing exercise. Professor Graham Easton, a GP who has been using weight loss jabs himself, said: 'I think it's a major issue about the proper funding and resourcing of not only the GPs in the surgeries but also the wraparound care we talked about. 'I think the other issue is that so far, to my knowledge, the NHS and National Institute for Health and Care Excellence have talked about this being something you take for two years, and that's probably related to data from research studies. 'But as we discussed, this is likely to be a lifelong commitment if it is going to be worthwhile to the NHS. 'There's no point in most people taking it for a couple of years and then have the weight bouncing back. 'You can argue possibly you're about to prepare for surgery or something, but in most cases it doesn't make any sense. 'Then I think there's a big issue around access. Most obesity occurs in poorer populations as wealthier populations tend to not be so affected. 'There's a massive sort of socio-economic inequality and there is a worry about this driving that inequality even further. 'Unless the NHS makes sure that these are available across the board equally, I think that's a major risk.' Prof Easton said recent studies had shown people who stopped taking the drugs had put the weight they lost back on within around a year. 'That's often true of any diet, people would say, and that's certainly my experience of having wrestled with my weight in diets over the years,' he said. 'All I would say that I found interesting from that review was that they were suggesting perhaps that weight returns even quicker after having been on GLP-1 drugs. 'Then speculating, because there was no way of knowing from that review, that perhaps it's because people are not changing the behaviours we've been talking about like exercise and other lifestyle changes, just relying on the drugs. 'When you stop them, of course, you're going to put weight back on. The switch is turned back off, or whatever it was. 'I mean very similar to, for example, statins or anti-hypertensive blood pressure medications, if you want lifelong effects, you have to keep on them lifelong.' Prof Easton was speaking at an event at the Cheltenham Science Festival discussing the growing use of weight loss drugs with neurophysiologist Dr Simon Cork and consultant endocrinologist and obesity expert Dr Tony Goldstone. Hundreds of thousands of people access weight-loss medication privately (PA) Dr Cork said the jabs have an important role to play in losing weight but are part of wider changes to diet and lifestyle. 'I think we have to understand that diet is always limited. People will tend to lose on average around 5% of their body weight on a diet,' he said. 'But you're hungry, you're miserable, you're tired, your wife hates you because you're so grumpy, you're not going to continue with that. 'But we should absolutely all be looking at our diet and all changing our diet, and doing something.' Dr Goldstone said weight loss drugs had been used in the treatment of diabetes for over a decade and had benefits of reducing the risk of developing other conditions. 'We're now in the third and fourth generation of these drugs, but the first generation of these drugs we've been using for 15 years for diabetes,' he said. 'There is nothing of concern that has emerged. In fact, all we're seeing are benefits. I'm not too worried about longer term side effects coming out. 'There is no real biological reason why there should be dangerous side-effects in the way that we know these drugs work. 'The benefits of the weight loss improvement in the diabetes are actually by themselves helping health and preventing other diseases, like cancer, heart attacks, renal failure, and potentially even reducing the risk of Alzheimer's disease. 'All those benefits, even if there was something that we hadn't really thought of that emerged down the line, I suspect that the harm of that is outweighed by the potential benefits of weight loss improvement in diabetes control.' Dr Cork said no drug is without side-effects and previous weight loss medications had failed because of them. 'There are side-effects, there are some concerning side-effects that tend to be very rare, but then you can monitor for those side-effects,' he said. 'As long as you're getting the correct care, as long as your GP is aware that you're taking them, then those should be identified. 'If you do find those side-effects, you can stop taking the drug.'
Sky News
an hour ago
- Sky News
'The only people I've ever seen in Gaza with weapons are the IDF,' says British surgeon
A British surgeon has told Sky News she has never treated or seen anyone in a Gaza hospital in military uniform - and the only people she has seen with weapons are the IDF. Dr Victoria Rose, a NHS plastic surgeon who has experience working in Gaza, said conditions there are now the worst they've ever been. "There's been a real escalation in the bombing campaign," she told Sunday Morning with Trevor Phillips. "The population is on their knees." Hospitals in Gaza have frequently come under Israeli military (IDF) fire - and sometimes find themselves besieged - in the ongoing war following Hamas's October 2023 attacks on Israel. Medical facilities are usually protected during conflicts under international law, but Israel has repeatedly claimed that Hamas uses them for command centres. Asked about Israel's allegations, Dr Rose said: "I've never treated or seen anyone - in any of the hospitals that I've worked in - in military uniform or with a weapon. "The only people I've ever seen in Gaza with military uniforms and weapons are the IDF." 3:21 Dr Rose told Sky News about the impact of the war on hospital staff: "Lots of my Palestinian colleagues were telling me that they would rather die than carry on with this war." It comes as a controversial humanitarian organisation backed by Israel and the US said it did not distribute any food in Gaza on Saturday, accusing Hamas of making threats that "made it impossible" to operate. Hamas denied the claims. 8:49 The Israeli blockade on aid going into Gaza has severely affected the population, she said, leaving them malnourished and without the nutrients they need. Speaking about her last visit to a hospital in the enclave, she said: "Infection rates were soaring... We were seeing a lot of avoidable deaths, a lot of small children dying from sepsis that would have been prevented if they'd been in in the Western world." Despite a limited lifting of the blockade by Israel - the head of the UN called it a "teaspoon" - the aid situation in Gaza remains dire. The Gaza Humanitarian Foundation (GHF), which is endorsed by Israel and the US, took over responsibility for distributing aid in Gaza, but has been criticised for lack of experience, organisation and faces allegations of assisting in ethnic cleansing by luring Palestinians to the south of the enclave if they want food. 2:38 The Hamas-run Gaza government media office said on Saturday the GHF operation has "utterly failed on all levels" and that Hamas was ready to help secure aid deliveries by a separate long-running UN-led humanitarian operation. A Hamas source told Reuters the group's armed wing would deploy snipers on Sunday to prevent armed gangs looting food shipments.
